CPA
ANGO icon

Capital Performance Advisors’s AngioDynamics ANGO Stock Holding History

Capital Performance Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,105
Closed -$8.6K – 310
2024
Q3 		$8.6K Buy
+1,105
New +$7.98K ﹤0.01% 897

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Capital Performance Advisors's ANGO Position: Q4 2024 in Review

Capital Performance Advisors sold out of AngioDynamics (ANGO) in Q4 2024, closing a stake of 1,105 shares — an estimated $8.6K sold.

Capital Performance Advisors first reported a position in ANGO in Q3 2024 and held it in 1 quarter. The position peaked at $8.6K in Q3 2024. 135 funds tracked by Wall St. Rank hold ANGO as of Q4 2024.

  • Capital Performance Advisors reported no remaining AngioDynamics position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 1,105 AngioDynamics shares in Q4 2024, an estimated $8.6K.
  • Capital Performance Advisors first reported a position in AngioDynamics in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's AngioDynamics position peaked at $8.6K in Q3 2024.
  • 135 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.